I accept that the cardiovascular responses to spinal blockade formed only a small incidental part of this review. Unfortunately, however, this short sentence relating pulse and blood pressure solely to cephalad spread of spinal anaesthesia could encourage the anaesthetist erroneously to attribute a slowing heart exclusively to the height of the spinal block, so inducing a false sense of security.
In 1988, Caplan and colleagues 5 demonstrated the serious consequences of failing adequately to appreciate the significance of bradycardia during spinal anaesthesia. This warning sign must alert the anaesthetist to the possibility and hence the consequences of a dropping venous return, and cannot be passed off as a side-effect of cephalad spread of spinal anaesthesia.
Editor-We thank Drs Akerman and Hutter for their interest in our review, and are grateful for the opportunity to respond.
Dr Akerman raises an interesting point, but should recognize the various dynamics involved. These are both relevant and important. First, the definitive paper by Cooper and colleagues 3 did not appear until our review was well advanced in the publication process. Second, Cooper and colleagues 3 only studied their patients for 20 min after intrathecal injection, and it is well recognized that intrathecal spread will continue for at least 30 min. Thus, the third issue, that this was the first description of a previously unreported association, was made in a dynamic clinical situation. Before an influence of systemic vasopressor on intrathecal drug disposition can be accepted as definitive it will need confirmation, and preferably confirmation in patients whose blocks are followed for at least 30 min, if not longer. Type 2 error is not just a theoretical possibility; it happens.
Dr Hutter is correct in stating that extent of block is not the only factor that may contribute to perioperative bradycardia, but it is a major factor and we stand by our wording, particularly given the subject matter of this paper. The other issues have been discussed elsewhere, 6-8 including some thoughts on the series from Caplan and colleagues. Leucocyte depleted whole blood in elective surgery programs
Editor-The preparation of autologous blood components is regulated by rules that are derived from the production of homologous blood components. Whole blood units (WB) are stored and transfused as leucocyte-and plasma-depleted red blood cell concentrates (PRBCs) in order to minimize adverse reactions in the transfused patient. Adverse reactions caused by the plasma fraction are mainly a problem in the homologous setting. We found that leucocyte-depleted whole blood units (LD WB) stored for 35 days meet the quality requirements for transfusion of the European Council 1 and is a feasible option, in addition to PRBCs, for autologous transfusion, especially in hospitals without a blood bank.
Standard units (450 ml) of WB were collected from 12 healthy male donors (age range 28-59 yr) using bags with an integrated
